c="novel ABCB11 gene mutations" 1:3 1:6||t="test"||cui="C1412070"||tot="ABCB11 gene"||ns="-861"
c="phenotypic transition" 1:8 1:9||t="problem"||cui="C1705165"||tot="Nucleotide Transition Abnormality"||ns="-861"
c="BRIC2" 1:11 1:11||t="problem"||cui="C1854236"||tot="CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 2"||ns="-1000"
c="PFIC2" 1:13 1:13||t="problem"||cui="C1866138"||tot="CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2"||ns="-1000"
c="ursodeoxycholic acid" 2:10 2:11||t="medication"||cui="C0042105"||tot="Ursodiol"||ns="-1000"
c="two novel ABCB11 gene mutations" 2:17 2:21||t="test"||cui="C1412070"||tot="ABCB11 gene"||ns="-840"
c="BRIC2" 2:47 2:47||t="problem"||cui="C1854236"||tot="CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 2"||ns="-1000"
c="PFIC2" 2:49 2:49||t="problem"||cui="C1866138"||tot="CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2"||ns="-1000"
